Tony Hitchcock
The Translation of Next Generation Therapeutics
March 22 by Tony HitchcockWhen we look at the current trends with what we can refer to as “next generation therapeutics”, whether it be ADCs or cell and gene therapy products, one trend is very clear, products are becoming inc...
Fit for Purpose
September 22 by Tony HitchcockAt Cobra we have worked on the development of both naked plasmid DNA and viral gene therapy products for over 20 years. After some rather extended development times, it has been very rewarding to se...
Disposables Solutions 2015
February 09 by Tony HitchcockWith this year’s Disposables Solutions meeting in Munich rapidly approaching I will focus this blog on some of the issues which I hope will be covered in presentations and discussions. Looki...
If Single Use is now the Norm
September 18 by Tony HitchcockOne of the most significant challenges facing the Bio-Pharm industry in recent years has been how to reduce development timelines and cost; billons of dollars have been invested in this area, with s...
Where Next for Single Use Systems?
June 12 by Tony HitchcockDuring recent meetings I have attended on single use systems it is apparent that whilst there is the acceptance that single use systems are now mainstream, there are still “growing pains&rdquo...
What are the Real Drivers in the Disposables Market?
February 05 by Tony HitchcockIn my last blog ahead of the Disposables Solutions meeting in Munich next month, I said that I would be looking a two key areas, which would feature in the discussion sessions during the meeting, th...
Flexible Facilities- Single Use Systems
December 09 by Tony HitchcockPharma IQ have kindly asked me to chair the forthcoming Disposable Solutions meeting next February in Munich, the meeting will focus as much on discussion sessions as it will on the more formal pres...
Implementing Single-Use Biomanufacturing Systems: What are the Challenges Ahead?
December 02 by Tony HitchcockIn this Pharma IQ interview Tony Hitchcock, Technical Director at Cobra Biologics, speaks to Andrea Charles from Pharma IQ, about why single use systems are not implemented more commonly across the...
An Image Problem in Biopharm?
October 17 by Tony HitchcockOver recent weeks I have been intrigued to hear some highly negative comments from people outside of the biopharm community on the industries economic value and also concerns regarding the public pe...
Moving Towards a More Mature Market Place
August 01 by Tony HitchcockI was fortunate enough to attend the Biotech 2013 Single-Use Technology in Biopharmaceutical Manufacturing meeting in Wädenswill, Switzerland in June, Eric Langer of BioPlan Associates stated &...
GSK Lead the Way with Staff Training for Disposables Implementation
March 25 by Tony HitchcockLast month saw the 5th Disposable Solutions meeting take place over two days in Brussels. We had an excellent mix of presentations not just from suppliers thankfully but more importantly fr...
Off the shelf bio-processing
January 22 by Tony HitchcockThe drivers for drug developers seeking to take products into clinical trails are nearly always cited as being cost and time, with timelines often being the over-riding driver. It is therefore not s...